2017Zhonghua shiyan waike zazhiRequires access

Effect of microRNA-223 on proliferation and migration of pancreatic cancer cell lines PANC-1 and miaPaCa-2

Cheng Huang, Longhui Xiong, Yumin Xu, Ke Hu, Guangnian Ma, Xinbing Chen, Dawei Liu, De He

Open publisher page 0 citations

Abstract

Objective To identify the effects of microRNA (miRNA, miR)-223 on proliferation and migration of pancreatic cancer cells. Methods miR-223 mimic and inhibitor were transfected into PANC-1 and miaPaCa-2 cell lines. The expression level of miR-223 was determined by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR). Cell proliferation was evaluated by methyl thiazol tetrazolium (MTT) assay. Transwell migration assy was performed for cell migration ability. Results The expression of miR-223 in the PANC-1 and miaPaCa-2 cell lines was significantly higher than that in normal pancreatic cells (8.21±0.83, 11.22±0.72, tPANC-1=14.886, P=0.000; tmiaPaCa-2=24.025, P=0.000). FQ-PCR showed the miR-223 expression level in PANC-1 and miaPaCa-2 cell lines were increased significantly after transfection with miR-223 mimics (8.18±0.82, 10.51±0.79, tPANC-1=15.221, P=0.001; tmiaPaCa-2=20.765, P=0.001). The number of pancreatic cancer cells in miR-223 tranfected group was extremely increased as compared with control group (1.43±0.07 vs. 0.49±0.08, t=15.715, P=0.000; 1.55±0.07 vs. 0.63±0.05, t=19.283, P=0.000). The number of migrated PANC-1 and miaPaCa-2 cells in miR-223 tranfected group was significantly greater than that in miR-23 control group (164.20±8.45 vs. 73.50±4.50, t=16.419, P=0.000; 133.45±7.75 vs. 56.40±6.25, t=13.401, P=0.000). The proliferation of pancreatic cancer was significantly decreased in miR-223 inhibitor transfected group as compared with that in miR-23 control group (0.73±0.06 vs. 1.04±0.05, t=6.754, P=0.000; 0.77±0.04 vs. 1.13±0.08, t=7.321, P=0.000). Transell results showed less cells in miR-223 inhibitor transfected group than in control group (35.30±3.36 vs. 72.60±4.10, t=16.419, P=0.000; 32.50±2.75 vs. 57.40±3.35, t=9.953, P=0.000). Conclusion The overexpression of miR-223 could remarkably promote the proliferation and migration abilities of human pancreatic cancer PANC-1 and miaPaCa-2 cells. Key words: MicroRNA-223; Pancratic cancer; Proliferation; Migration

About this research paper

What this paper is about

Objective To identify the effects of microRNA (miRNA, miR)-223 on proliferation and migration of pancreatic cancer cells. Methods miR-223 mimic and inhibitor were transfected into PANC-1 and miaPaCa-2 cell lines. The expression level of miR-223 was determined by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR). Cell proliferation was evaluated by methyl thiazol tetrazolium (MTT) assay. Transwell migration assy was performed for cell migration ability. Results The expression of miR-223 in the PANC-1 and miaPaCa-2 cell lines was significantly higher than that in normal pancreatic cells (8.21±0.83, 11.22±0.72, tPANC-1=14.886, P=0.000; tmiaPaCa-2=24.025, P=0.000). FQ-PCR showed the miR-223 expression level in PANC-1 and miaPaCa-2 cell lines were increased significantly after transfection with miR-223 mimics (8.18±0.82, 10.51±0.79, tPANC-1=15.221, P=0.001; tmiaPaCa-2=20.765, P=0.001). The number of pancreatic cancer cells in miR-223 tranfected group was extremely increased as compared with control group (1.43±0.07 vs. 0.49±0.08, t=15.715, P=0.000; 1.55±0.07 vs. 0.63±0.05, t=19.283, P=0.000). The number of migrated PANC-1 and miaPaCa-2 cells in miR-223 tranfected group was significantly greater than that in miR-23 control group (164.20±8.45 vs. 73.50±4.50, t=16.419, P=0.000; 133.45±7.75 vs. 56.40±6.25, t=13.401, P=0.000). The proliferation of pancreatic cancer was significantly decreased in miR-223 inhibitor transfected group as compared with that in miR-23 control group (0.73±0.06 vs. 1.04±0.05, t=6.754, P=0.000; 0.77±0.04 vs. 1.13±0.08, t=7.321, P=0.000). Transell results showed less cells in miR-223 inhibitor transfected group than in control group (35.30±3.36 vs. 72.60±4.10, t=16.419, P=0.000; 32.50±2.75 vs. 57.40±3.35, t=9.953, P=0.000). Conclusion The overexpression of miR-223 could remarkably promote the proliferation and migration abilities of human pancreatic cancer PANC-1 and miaPaCa-2 cells. Key words: MicroRNA-223; Pancratic cancer; Proliferation; Migration

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To identify the effects of microRNA (miRNA, miR)-223 on proliferation and migration of pancreatic cancer cells. Methods miR-223 mimic and inhibitor were transfected into PANC-1 and miaPaCa-2 cell lines. The expression level of miR-223 was determined by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR). Cell proliferation was evaluated by methyl thiazol tetrazolium (MTT) assay. Transwell migration assy was performed for cell migration ability. Results The expression of miR-223 in the PANC-1 and miaPaCa-2 cell lines was significantly higher than that in normal pancreatic cells (8.21±0.83, 11.22±0.72, tPANC-1=14.886, P=0.000; tmiaPaCa-2=24.025, P=0.000). FQ-PCR showed the miR-223 expression level in PANC-1 and miaPaCa-2 cell lines were increased significantly after transfection with miR-223 mimics (8.18±0.82, 10.51±0.79, tPANC-1=15.221, P=0.001; tmiaPaCa-2=20.765, P=0.001). The number of pancreatic cancer cells in miR-223 tranfected group was extremely increased as compared with control group (1.43±0.07 vs. 0.49±0.08, t=15.715, P=0.000; 1.55±0.07 vs. 0.63±0.05, t=19.283, P=0.000). The number of migrated PANC-1 and miaPaCa-2 cells in miR-223 tranfected group was significantly greater than that in miR-23 control group (164.20±8.45 vs. 73.50±4.50, t=16.419, P=0.000; 133.45±7.75 vs. 56.40±6.25, t=13.401, P=0.000). The proliferation of pancreatic cancer was significantly decreased in miR-223 inhibitor transfected group as compared with that in miR-23 control group (0.73±0.06 vs. 1.04±0.05, t=6.754, P=0.000; 0.77±0.04 vs. 1.13±0.08, t=7.321, P=0.000). Transell results showed less cells in miR-223 inhibitor transfected group than in control group (35.30±3.36 vs. 72.60±4.10, t=16.419, P=0.000; 32.50±2.75 vs. 57.40±3.35, t=9.953, P=0.000). Conclusion The overexpression of miR-223 could remarkably promote the proliferation and migration abilities of human pancreatic cancer PANC-1 and miaPaCa-2 cells. Key words: MicroRNA-223; Pancratic cancer; Proliferation; Migration

Key concepts: microRNA, Transfection, Pancreatic cancer, Cell growth, Chemistry, Cell culture, Molecular biology, Real-time polymerase chain reaction

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of microRNA-223 on proliferation and migration of pancreatic cancer cell lines PANC-1 and miaPaCa-2 — Research Paper | ScholarLens